The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma.
The use of chemotherapy regimens with moderate or high risk of febrile neutropenia (defined as having a FN incidence of 10% or more) and the respective incidence and clinical management of FN in breast cancer and NHL has not been studied in Belgium. The existence of a medical need for G-CSF primary and secondary prophylaxis with these regimens was investigated in a real-life setting. ; Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't ; SCOPUS: ar.j ; info:eu-repo/semantics/published
| Verfasser: |
Gerlier, L.
Lamotte, Mark
Awada, Ahmad
Bosly, André
Bries, G.
Cocquyt, Veronique
Focan, Christian
Henry, Sarah
Lalami, Yassine
Machiels, Jean Pascal
Mebis, J.
Straetmans, N.
Verhoeven, D.
Somers, L. |
| Dokumenttyp: |
Artikel |
| Erscheinungsdatum: |
2010 |
| Schlagwörter: |
Cancérologie
/ Academic Medical Centers
/ Adult
/ Aged
/ Antineoplastic Combined Chemotherapy Protocols -- adverse effects
/ Belgium -- epidemiology
/ Breast Neoplasms -- drug therapy -- epidemiology
/ Female
/ Fever -- chemically induced -- epidemiology -- prevention & control
/ Granulocyte Colony-Stimulating Factor -- therapeutic use
/ Guideline Adherence
/ Health Care Surveys
/ Hospitalization
/ Hospitals
/ General
/ Humans
/ Incidence
/ Lymphoma
/ Non-Hodgkin -- drug therapy -- epidemiology
/ Male
/ Middle Aged
/ Neutropenia -- chemically induced -- epidemiology -- prevention & control
/ Physician's Practice Patterns
/ Practice Guidelines as Topic
/ Retrospective Studies
/ Time Factors
/ Treatment Outcome
/ Young Adult |
| Sprache: |
Englisch |
| Permalink: |
https://search.fid-benelux.de/Record/base-26588582 |
| Datenquelle: |
BASE;
Originalkatalog |
| Powered By: |
BASE |
| Link(s) :
|
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/117813 |
